- Guide to PHARMACOLOGY
Compound class: Synthetic organic
Comment: Compound 4 is from a series of antimalarial hexahydropyrimidine analogues claimed in UCB Biopharma patent WO2022008639A1 .
1. De Haro Garcia T, Frost JR, Lallemand B, Lowe MA. (2022)
Antimalarial hexahydropyrimidine analogues.
Patent number: WO2022008639A1. Assignee: UCB Biopharma SRL. Priority date: 10/07/2020. Publication date: 13/01/2022.